Scheme 1
Scheme 3
the anticipated facile ring closure of the piperidine ring on
the acetylene moiety of pentacycle 11 would provide alkene
10, a handle for the introduction of the C(11) epoxide
substituent. It seemed likely that the intramolecular cycload-
dition of the N-acyl-aza-ortho-xylylene would also proceed
through the endo transition state 12 with the ester substituent
occupying a position on the convex face.2b However, we were
concerned about the ramifications of the C(12a) substituent
which emerges in a highly congested environment, hence
the choice of the compact ethynyl group. Moreover, it was
anticipated that the primary amine of indole 15, vis-a`-vis
the secondary amine of benzazepine 1, would allow the
efficient assembly of various aza-ortho-xylylene precursors.
In particular, we were intrigued by the prospect of preparing
the aziridine 13 by sequential substitution reactions of
dibromide 14 with tryptamine 15 for the purpose of examin-
ing its acid- or base-induced ring opening as a means for
generating the desired N-acyl-aza-ortho-xylylene 12.5
We began this investigation by preparing an aziridine that
lacked the potentially problematic C(12a) ethynyl substituent
(Scheme 4). Thus, alkylation of 1-methyltryptamine with the
dibromide 14 provided the trans aziridine 16 in good yield.
The stereochemistry of the aziridine was assigned as trans
based upon the observed vicinal coupling constant of 2.8
Hz. This value is quite similar to the vicinal coupling
constants reported for related trans aziridines and is smaller
than the coupling constant that would be expected for the
cis diastereomer (6-7 Hz).6
Accordingly, we examined the aminolysis of epoxide 8 with
the benzazepine 1. Unfortunately, we were unable to obtain
any of the desired alcohol 9 using a variety of reaction
conditions.3
Scheme 2
We could now evaluate whether protonation of the
aziridine 16 would lead to its ring opening and afford the
In view of these difficulties, we decided to investigate a
synthesis that is more closely related to possible biosynthetic
pathways.2a,c,4 Specifically, the synthesis would begin with
a tryptamine derivative thereby necessitating elaboration of
the seven-membered ring later in the synthetic sequence
(Scheme 3). One advantage of this redesigned route is that
(4) (a) Fuchs, J. R.; Funk, R. L. J. Am. Chem. Soc. 2004, 126, 5068. For
labeling studies consistent with the tryptamine dimerization pathway
previously proposed for the calycanthaceous alkaloids, see: (b) Wigley, L.
J.; Mantle, P. G.; Perry, D. A. Phytochemistry 2006, 67, 561. For seminal
examples of proposed calycanthaceous alkaloid biosynthesis, see: (c)
Woodward, R. B.; Yang, N. C.; Katz, T. J. Proc. Chem. Soc. 1960, 76. (d)
Robinson, R.; Teuber, H. J. Chem. Ind. 1954, 783.
(3) (a) Fujiwara, M.; Imada, M.; Baba, A.; Matsuda, H. Tetrahedron
Lett. 1989, 30, 739. (b) Chini, M.; Crotti, P.; Favero, L.; Macchia, F.;
Pineschi, M. Tetrahedron Lett. 1994, 35, 433. (c) Kotsuki, H.; Shimanouchi,
T.; Teraguchi, M.; Kataoka, M.; Tatsukawa, A.; Nishizawa, H. Chem. Lett.
1994, 2159. (d) Meguro, M.; Asao, N.; Yamamoto, Y. J. Chem. Soc., Perkin
Trans. 1 1994, 2597. (e) Chakraborti, A. K.; Kondaskar, A. Tetrahedron
Lett. 2003, 44, 8315 and references therein.
(5) For a review on the synthesis and applications of aza-ortho-xylylenes,
see: Wojciechowski, K. Eur. J. Org. Chem. 2001, 3587.
(6) For similar aziridine syntheses, see: (a) Ploux, O.; Caruso, M.;
Chassaing, G.; Marquet, A. J. Org. Chem. 1988, 53, 3154. (b) Toke´s, A.;
Likei, G.; Janzso´, G. Synth. Commun. 1990, 20, 1905. (c) Davoli, P.; Forni,
A.; Moretti, I.; Prati, F.; Torre, G. Tetrahedron 2001, 57, 1801. (d)
Comstock, L. R.; Rajski, S. R. Tetrahedron 2002, 58, 6019.
3996
Org. Lett., Vol. 8, No. 18, 2006